Want to see PASG full AI Analyst Report?
Passage Bio (PASG) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pbkr03 | Leukodystrophy, Globoid Cell | phase1AndPhase2 | Suspended | Study of Safety, Tolerability and Efficacy of PBKR03 in Pediatric Subjects With Early Infantile Krabbe Disease | Feb 23, 2021 | ― |
| Pbft02 | Frontotemporal Dementia, Ftd, Ftd-Grn, Dementia Frontotemporal, C9orf72 | phase1AndPhase2 | Recruiting | A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes | Feb 02, 2021 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Pbkr03 | phase1AndPhase2 | Leukodystrophy, Globoid Cell | Suspended | Study of Safety, Tolerability and Efficacy of PBKR03 in Pediatric Subjects With Early Infantile Krabbe Disease | Feb 23, 2021 | ― |
| Pbft02 | phase1AndPhase2 | Frontotemporal Dementia, Ftd, Ftd-Grn, Dementia Frontotemporal, C9orf72 | Recruiting | A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes | Feb 02, 2021 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Passage Bio, Inc. (PASG) have in its pipeline
Passage Bio PASG is currently developing the following drugs: Pbkr03, Pbft02. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
